Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
Status:
Completed
Trial end date:
2013-11-30
Target enrollment:
Participant gender:
Summary
This is an open-label study for patients who participated in the BPS-MR-PAH-203 study and
have volunteered to continue treatment for PAH with Beraprost Sodium Modified Release
(BPS-MR) tablets.